Immunotherapy: Adapt and survive
- PMID: 23076155
- DOI: 10.1038/nrc3387
Immunotherapy: Adapt and survive
Comment on
-
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation.Nature. 2012 Oct 18;490(7420):412-6. doi: 10.1038/nature11538. Epub 2012 Oct 10. Nature. 2012. PMID: 23051752
References
-
- Nature. 2012 Oct 18;490(7420):412-6 - PubMed
Publication types
LinkOut - more resources
Full Text Sources